Oncologists Drive Advancements in Oncosciences at ‘Hemato-Onco Update 2.0’ by Sterling Hospitals. The conference topics are – latest advancements in antibody-drug conjugates for lymphoma, CAR T-cell therapy, breast cancer prognostication tools, and the integration of artificial intelligence in cancer diagnostics and treatment planning.
Vadodara: Sterling Hospitals successfully hosted the ‘Hemato-Onco Update 2.0’, a high-impact academic conclave dedicated to the evolving landscape of oncosciences, with a special focus on hemato-oncology. The event brought together over 200 eminent oncologists and specialists, fostering discussions on cutting-edge advancements, evidence-based treatment protocols, and the future of cancer care.
The conference was formally inaugurated by Chief District Health Officer (CDHO) Dr. Meenakshi and IMA Vadodara President Dr. Mitesh Shah, marking a significant moment in advancing oncosciences. The event witnessed the presence of leading oncologists, including Dr. M.B. Aggarwal and Dr. Purvesh Parikh, both recognized experts in hemato-oncology, who shared valuable insights on treatment innovations and evolving research in the field.
With India witnessing a rising burden of hematologic malignancies, including leukemia, lymphoma, and multiple myeloma, there is an urgent need for enhanced diagnostic techniques, targeted therapies, and multidisciplinary collaborations to improve survival outcomes. Over 100,000 patients are diagnosed with blood cancers annually, underscoring the necessity for continuous advancements in research and clinical practices.
Dr. Simmardeep Singh Gill, Managing Director & CEO of Sterling Hospitals, highlighted the hospital’s commitment to advancing cancer care through clinical excellence and continuous learning. He remarked, “Oncosciences is witnessing transformative breakthroughs, and Sterling Hospitals remains at the forefront of integrating these advancements into patient care. Platforms like ‘Hemato-Onco Update 2.0’ play a crucial role in bridging research and real-world applications, ensuring that patients receive the best possible treatment solutions.”
Addressing the gathering, Dr. Vibha Naik, Director of Medical Oncology and Bone Marrow Transplant at Sterling Hospitals, emphasized that while technology has brought remarkable improvements in treatment outcomes, the essence of cancer care must also prioritize patient well-being and empathetic communication. She stated, “Beyond clinical success, ensuring a patient-centric approach is key. As oncologists, we need to guide patients and their families through their treatment journey with clarity, compassion, and a focus on quality of life.”
Dr. Ansif Abraham, Facility Director of Sterling Hospitals, Bhayli, which serves as a dedicated centre for comprehensive cancer care, further emphasized the significance of such academic forums. He noted, “Sterling Hospitals is committed to fostering knowledge exchange among oncologists, ensuring that the latest innovations in treatment and research are seamlessly incorporated into clinical practice. Our goal is to empower specialists with the tools they need to deliver world-class cancer care with precision and compassion.”
The conference delved into breakthrough topics, including the latest advancements in antibody-drug conjugates for lymphoma, CAR T-cell therapy, breast cancer prognostication tools, and the integration of artificial intelligence in cancer diagnostics and treatment planning. The event concluded with an inter-college oncology quiz, reinforcing academic collaboration and engagement among attendees.
Sterling Hospitals was recently recognized as the Best Oncology Hospital, a testament to its commitment to clinical excellence and compassionate cancer care.
Sterling Hospitals: Pioneering Oncosciences in Gujarat
Sterling Hospitals has cemented its position as a leader in tertiary healthcare and oncosciences, offering comprehensive cancer care across its four advanced hospitals and cancer centres in Ahmedabad, Vadodara, Rajkot, and Gandhidham. With cutting-edge technology, including robotic-assisted surgeries, advanced radiation therapy, and precision diagnostics, Sterling provides multidisciplinary, patient-centric oncology treatment that combines clinical expertise with compassionate care.
As a trusted institution in oncosciences, Sterling Hospitals remains dedicated to bridging the gap between research, innovation, and real-world patient outcomes, ensuring that every cancer patient receives the highest standard of care with an unwavering commitment to excellence.
